NL-OMON20671尚未招募不适用
Portal vein Obstruction Revascularisation Therapy After Liver transplantation registry
niversity Medical Centre Groningen (UMCG)0 个研究点目标入组 400 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 400
研究概览
简要总结
one
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Treated for PVO (PVAS or PVT) after liver transplantation (all interventions are included and conservative treatment as well)
- •2. Age at intervention <18 years
- •3. Intervention in period 01-01-2001 and 01-01-2021
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Results of study to increase liver size by embolisation in patients of liver surgery.CTRI/2016/04/006794one20
尚未招募
2 期
Treatment of portal, mesenteric, and splenic vein thrombosis with rivaroxaban. A pilot, prospective cohort studyabdominal vein thrombosisSplanchic thrombosis10014523NL-OMON48974niversità degli Studi dell'Insubria5
进行中（未招募）
1 期
Treatment of thrombosis in the abdominal veinsSplanchnic vein thrombosis (SVT) is an unusual site manifestation of venous thromboembolism (VTE). It includes the Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT), mesenteric vein thrombosis (MVT) and splenic vein thrombosis (spVT). PVT is the most frequent manifestation of SVT, followed by MVT.EUCTR2014-005162-29-NLniversity of Insubria100
尚未招募
不适用
The effect of portal vein embolisation on portal venous perfusion of the liverPrimary or secondary liver tumor.10019654NL-OMON34722Academisch Medisch Centrum45
招募中
不适用
Assessment of the effect of portal venous embolization by MRI uging liver specificity contrast materialHepatobiliary malignancyJPRN-UMIN000003079Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo,75